Manidipine

DB09238ApprovedInvestigationalWithdrawnSmall molecule

Manidipine is a dihydropyridine calcium channel blocker used to treat hypertension. It is selective for vasculature and does not produce effects on the heart at clinically relevant dosages.

Chemical structure of Manidipine
Mechanism
Curator reviewed · 2 references
Primary indication
For the treatment of hypertension.Curator reviewed · 1 structured indication
Formula / weight
C35H38N4O6 · 610.711 g/mol (avg)

Resolves to

Structure
InChIKeyANEBWFXPVPTEET-UHFFFAOYSA-NSMILESCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)N(=O)=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1

What you can answer from here — as of September 23, 2026

9Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,420Drug interactionsStructured to mechanism, not free text
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
114Marketed productsAcross 4 countries and 20 labellers
Sign in
2ATC codesIncluding every combination product, plus 31 drug categories
Sign in
22+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Manidipine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account